ENTRY       D01223                      Drug
NAME        Capecitabine (JAN/USAN/INN);
            Xeloda (TN)
PRODUCT     XELODA (Genentech) a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8
            XELODA (Physicians Total Care) 6b76b5bb-1d69-43f9-99c6-f39a0b6d8a26
            XELODA (State of Florida DOH Central Pharmacy) a732b303-9bbd-42ba-a7c5-61c21629ba93
  GENERIC   CAPECITABINE (Accord Healthcare) 8345d55e-ad02-4726-a04b-1a46e3337a4b
            CAPECITABINE (American Health Packaging) 2777b481-7d7f-461a-b5e0-c09ce2990c34
            CAPECITABINE (Amneal Pharmaceuticals LLC) 30830d24-1421-4c25-9b6b-c15705aa4357
            CAPECITABINE (AvKARE) 621280e2-894f-4e61-856e-63c9d24b6e49
            CAPECITABINE (AvKARE) b2c7b4ba-831c-a80f-3078-145017268657
            CAPECITABINE (KAISER FOUNDATION HOSPITALS) 5a49df30-a723-4c02-9c78-b61fef428d78
            CAPECITABINE (KAISER FOUNDATION HOSPITALS) 715ef37e-e700-4009-89ca-f5018c480c63
            CAPECITABINE (KAISER FOUNDATION HOSPITALS) b17f49a7-9fc0-4aef-a7b5-42384b29d3bc
            CAPECITABINE (Mylan Institutional) 16145a4c-a3d0-404b-bd58-3f220a45ef73
            CAPECITABINE (Mylan Pharmaceuticals) 03dd3301-e9ce-40af-84e1-7b70fc6557b0
            CAPECITABINE (Northstar RxLLC) 7b260da3-dee2-4bbb-9235-39b16720d578
            CAPECITABINE (Rising Pharmaceuticals) 01bf8c52-7f60-4fa5-8257-847bc0d910a4
            CAPECITABINE (Shilpa Medicare Limited) 7fcc87e4-6fb3-4723-a1fb-873e4a916a55
            CAPECITABINE (Teva Pharmaceuticals USA) 5753679a-506c-4ac4-b8b2-b27c664d1d40
            CAPECITABINE (West-Ward Pharmaceuticals Corp.) 17749bb8-dd33-49cc-95c9-45c7fefa6e78
FORMULA     C15H22FN3O6
EXACT_MASS  359.1493
MOL_WEIGHT  359.3501
CLASS       Antineoplastic
             DG01958  Nucleic acid derivative, antineoplastic
              DG01439  Arabinofuranosyl type antineoplastic
              DG01935  Fluoropyrimidine antineoplastic
             DG01439  Arabinofuranosyl type antineoplastic
             DG01935  Fluoropyrimidine antineoplastic
            Unclassified
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01439  Arabinofuranosyl type antineoplastic
               DG01935  Fluoropyrimidine antineoplastic
REMARK      Same as: C12650
            Therapeutic category: 4223
            ATC code: L01BC06
ACTIVITY    Antineoplastic, Antimetabolite
COMMENT     5,10-Methylenetetrahydrofolate [CPD:C00143]
TARGET      TYMS [HSA:7298] [KO:K00560]
  PATHWAY   hsa00240(7298)  Pyrimidine metabolism
            hsa00670(7298)  One carbon pool by folate
METABOLISM  Enzyme: CYP2C9 [HSA:1559]
INTERACTION Genomic biomarker: DPYD [HSA:1806]
STR_MAP     map07041  Antineoplastics - antimetabolic agents
OTHER_MAP   map00983  Drug metabolism - other enzymes
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC06 Capecitabine
                  D01223  Capecitabine (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4223  Fluorouracils
                 D01223  Capecitabine (JAN/USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases
               thymidylate synthase
                Capecitabine
                 D01223  Capecitabine (JAN/USAN/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP inhbitors
              CYP2C9
               Capecitabine
                D01223  Capecitabine (JAN/USAN/INN)
             CYP substrates
              CYP2C9
               Capecitabine
                D01223  Capecitabine (JAN/USAN/INN)
            Antineoplastics [br08340.html]
             D01223
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01223
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01223
            Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
             Polymorphisms and germline mutations
              D01223
DBLINKS     CAS: 154361-50-9
            PubChem: 7848286
            ChEBI: 31348
            ChEMBL: CHEMBL1773
            DrugBank: DB01101
            LigandBox: D01223
            NIKKAJI: J949.163E
ATOM        25
            1   C1y C    11.2700  -21.5600
            2   C1y C    12.6700  -21.5600
            3   C1y C    13.1600  -20.2300
            4   O2x O    11.9700  -19.4600
            5   C1y C    10.8500  -20.2300
            6   C1a C     9.5200  -19.8100
            7   O1a O    10.4300  -22.7500
            8   O1a O    13.5100  -22.7500
            9   N4y N    14.4900  -19.8100
            10  C8y C    15.6800  -20.5100
            11  N5x N    16.9400  -19.8100
            12  C8y C    16.9400  -18.4100
            13  C8y C    15.7500  -17.7100
            14  C8x C    14.4900  -18.4100
            15  O5x O    15.6800  -21.9100
            16  X   F    15.7500  -16.3800
            17  N1b N    18.1300  -17.7100
            18  C7a C    19.3200  -18.4100
            19  O7a O    20.5100  -17.7100
            20  C1b C    21.7000  -18.4100
            21  C1b C    22.8900  -17.7100
            22  C1b C    24.0800  -18.4100
            23  C1b C    25.2700  -17.7100
            24  C1a C    26.4600  -18.4100
            25  O6a O    19.3200  -19.8100
BOND        26
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     5   6 1 #Up
            7     1   7 1 #Down
            8     2   8 1 #Down
            9     3   9 1 #Up
            10    9  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15    9  14 1
            16   10  15 2
            17   13  16 1
            18   17  18 1
            19   17  12 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 1
            26   18  25 2
///
